Register to receive the virtual meeting link for
our upcoming webinar joint with ASPET's Drug Metabolism and Disposition Division
Current Advances in Drug Metabolism - Industry Focus
Hear from
Robert S. Jones, Ph.D.,
Principal Scientist, Drug Metabolism & Pharmacokinetics,
Genetech, San Francisco, California
on
"Application of empirical scalars to enable early prediction of human hepatic clearance using in vitro-in vivo extrapolation in drug discovery"
Dr. Robert S. Jones is currently a Principal Scientist in the department of Drug Metabolism and Pharmacokinetics (DMPK) at Genentech Inc. There he works within the PK/Transport Group to develop translational in vitro models and in silico approaches for improving the translation of preclinical data to human, both from a project, and investigative research perspective. In this webinar, Dr. Jones will discuss a recently published approach utilizing empirical scalars on early drug discovery data to improve current predictions of human clearance
and from
Sebastian D. Parlee, Ph.D.,
Sr. D&I Engagement Partner, Organizational Effectiveness, R&ED Executive Office,
Novo Nordisk, Boston, Massachusetts
on
"Innovation through Diversification: Novo Nordisk Research & Early Development Essential #6 Strategy"
Our Fundamental goal in Research and Early Development (R&ED) at Novo Nordisk is to identify and develop next generation life saving medicines for our patients. An inclusive culture is a prerequisite for this as our people must feel safe to bring their whole selves to work and challenge the status quo for innovation to occur. In this webinar, our philosophy, values and strategy for building this respectful global culture as well as attracting and unifying diverse talent will be presented
